0310-0209 : Zomig-zmt 2.5 mg Disintegrating Tablet


NDC0310-0209
Labeler: Astrazeneca Pharmaceuticals Lp
Product Type: Human Prescription Drug
Drug Name:  Zomig Zmt
Dosage Form: Oral Tablet, Orally Disintegrating
Application #: NDA021231
Rev. Date: 


Appearance:


Markings: Z
Shapes:  Round
Colors:  White
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Z: (0310-0209) Zomig-zmt 2.5 mg Disintegrating Tablet by Astrazeneca Pharmaceuticals Lp
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0310-0209-20: 6 BLISTER PACK IN 1 CARTON (0310‑0209‑20) > 6 TABLET, ORALLY DISINTEGRATING IN 1 BLISTER PACK

Active Ingredients:

  • Zolmitriptan

Dosage Strength:

  • 2.5 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Magnesium Stearate
  • Crospovidone
  • Aspartame
  • Sodium Bicarbonate
  • Citric Acid Anhydrous
  • Silicon Dioxide
  • Orange
  • Mannitol

Pharmaceutical Classes:

  • Serotonin 1b Receptor Agonists [MoA]
  • Serotonin 1d Receptor Agonists [MoA]
  • Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0310-0213 Zomig-zmt 5 mg Disintegrating Tablet by Astrazeneca Pharmaceuticals Lp
  • 64896-691 Zomig-zmt 2.5 mg Disintegrating Tablet by Impax Laboratories, Inc.
  • 64896-692 Zomig-zmt 5 mg Disintegrating Tablet by Impax Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0310-0209 QR Code

< Prev: 0310-0208Next: 0310-0210 >

Related Discussions:

zolmitriptan
label of ascotop and zomig...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.